We are live on ! Find out more
DGM

Darwin Global Management Portfolio holdings

AUM $3.77B
1-Year Est. Return 307.72%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+307.72%
3 Year Est. Return
+2,873.14%
5 Year Est. Return
+48,315.58%
10 Year Est. Return
–
AUM
$284M
AUM Growth
-$328M
Cap. Flow
-$301M
Cap. Flow %
-105.85%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
IMVT icon
Immunovant
IMVT
+$41.1M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$230M
2
ARGX icon
argenx
ARGX
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAM
1
DELISTED
Ambrx Biopharma Inc
AMAM
$192M 67.54%
16,688,636
– –
IMVT icon
2
Immunovant
IMVT
$8.27B
$69.8M 24.57%
+1,818,371
New +$41.1M
ARGX icon
3
argenx
ARGX
$53.8B
$22.4M 7.89%
45,615
-227,728
-83% -$111M
TGTX icon
4
TG Therapeutics
TGTX
$8.4B
– –
-9,278,439
Closed -$230M

Similar funds

VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
ABC
Associated Banc-Corp Green Bay, Wisconsin $3.78B AUM 21.74% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
VA
VestGen Advisors Inverness, Illinois $3.76B AUM 26.04% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return

Darwin Global Management's Q3 2023 Portfolio in Review

As of Q3 2023, Darwin Global Management held 4 positions worth $284M, down 54% from $612M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Darwin Global Management withdrew a net $301M in Q3 2023, closing 1 position and reducing 1 holding. Its most notable exit was TG Therapeutics, an estimated $230M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Darwin Global Management opened a new position in Immunovant worth $69.8M.

  • Darwin Global Management's largest Q3 2023 buy was Immunovant: 1,818,371 shares worth $69.8M.
  • Darwin Global Management's biggest Q3 2023 reduction was argenx, cutting an estimated $111M.
  • Darwin Global Management fully exited TG Therapeutics in Q3 2023, selling an estimated $230M.
  • Darwin Global Management's ten largest holdings make up 100% of its $284M portfolio in Q3 2023.
  • Darwin Global Management opened 1 new position and closed 1 in Q3 2023.
  • Darwin Global Management's portfolio value fell 54% quarter-over-quarter to $284M.

Based on Darwin Global Management's 13F filing for Q3 2023, filed 14 Nov 2023.